Premium
Commentary: real‐world triple therapy experience treating hepatitis C virus – authors' reply
Author(s) -
Bichoupan K.,
Schwartz J. M.,
MartelLaferriere V.,
Giannattasio E. R.,
Marfo K.,
Odin J. A.,
Liu L. U.,
Schiano T. D.,
Perumalswami P.,
Bansal M.,
Gaglio P. J.,
Kalia H.,
Dieterich D. T.,
Branch A. D.,
Reinus J. F.
Publication year - 2014
Publication title -
alimentary pharmacology and therapeutics
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12641
Subject(s) - medicine , ribavirin , adverse effect , regimen , hepatitis c virus , hepatitis c , erythropoietin , intensive care medicine , pediatrics , virus , virology